Dual molecular axis of resistance and immunoresponsiveness to BCG in pT1 non-muscle invasive bladder cancer: Insights from HER-2, SERBP1, HABP4, and IFN-γ profiling.
第一单位:
Laboratory of Urogenital Carcinogenesis and Immunotherapy (LCURGIN), Universidade Estadual de Campinas (UNICAMP), Campinas, São Paulo, Brazil; Paulínia Municipal Hospital, Paulínia, São Paulo, Brazil. Electronic address: jocaalonso1@gmail.com.
作者:
医学主题词
人类(Humans);膀胱肿瘤(Urinary Bladder Neoplasms);女(雌)性(Female);男(雄)性(Male);老年人(Aged);中年人(Middle Aged);卡介苗(BCG Vaccine);成年人(Adult);老年人, 80以上(Aged, 80 and over);干扰素γ(Interferon-gamma);肿瘤侵润(Neoplasm Invasiveness);抗药性, 肿瘤(Drug Resistance, Neoplasm);回顾性研究(Retrospective Studies)
DOI
10.1016/j.tice.2025.103137
PMID
40967126
发布时间
2025-12-24
- 浏览0
Tissue & cell
103137页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



